Security National Bank of Sioux City Iowa IA Buys 2,939 Shares of iShares Biotechnology ETF $IBB

Posted by George Bondi on Sep 18th, 2026

Security National Bank of Sioux City Iowa IA boosted its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 31.8% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 12,187 shares of the financial services provider’s stock after purchasing an additional 2,939 shares during the quarter. Security National Bank of Sioux City Iowa IA’s holdings in iShares Biotechnology ETF were worth $2,318,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. The Manufacturers Life Insurance Company lifted its position in shares of iShares Biotechnology ETF by 64.0% in the second quarter. The Manufacturers Life Insurance Company now owns 101,838 shares of the financial services provider’s stock worth $19,369,000 after buying an additional 39,760 shares in the last quarter. Sequoia Financial Advisors LLC grew its holdings in iShares Biotechnology ETF by 5.4% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 3,258 shares of the financial services provider’s stock valued at $620,000 after buying an additional 166 shares in the last quarter. Tidal Investments LLC purchased a new position in iShares Biotechnology ETF during the 2nd quarter valued at approximately $1,512,000. NorthRock Partners LLC increased its stake in iShares Biotechnology ETF by 51.8% in the 2nd quarter. NorthRock Partners LLC now owns 1,940 shares of the financial services provider’s stock worth $369,000 after acquiring an additional 662 shares during the last quarter. Finally, Community Bank N.A. increased its stake in iShares Biotechnology ETF by 5.2% in the 2nd quarter. Community Bank N.A. now owns 1,483 shares of the financial services provider’s stock worth $282,000 after acquiring an additional 73 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 1.2%

Shares of IBB traded down $2.51 during mid-day trading on Friday, hitting $204.56. 1,355,060 shares of the stock were exchanged, compared to its average volume of 1,639,238. iShares Biotechnology ETF has a 52-week low of $138.79 and a 52-week high of $217.12. The firm has a 50-day moving average of $200.00 and a two-hundred day moving average of $182.22.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 18th. Investors of record on Tuesday, September 15th will be given a $0.0112 dividend. This represents a $0.04 annualized dividend and a yield of 0.0%. The ex-dividend date is Tuesday, September 15th.

About iShares Biotechnology ETF

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.